Početna › Bronhijalni karcinom › Illinois
Kliničke studije za Bronhijalni karcinom u državi Illinois
5 studija za Bronhijalni karcinom traži sudionike na lokacijama u državi Illinois.
Gradovi u državi Illinois
Službeni tekst studije (engleski)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
- Springfield Clinic Main Campus, Springfield
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
- Illinois Cancer Specialists, Arlington Heights
- University of Illinois Hospital and Health Sciences Systems, Chicago
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT07185997Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Advocate Aurora Health, Park Ridge
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 26. lip 2026. · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Edward Hines Jr. VA Hospital, Hines, IL, Hines
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 19. velj 2026. · NCT02984761Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.